{"database": "openregs", "table": "documents", "rows": [["FDA-2016-P-1026-0003", "FDA", "FDA-2016-P-1026", "Medical Devices; Exemption from Premarket Notification: Method, Metallic Reduction, Glucose (Urinary, Non-Quantitative) Test System in a Reagent Tablet Format; Republication", "Notice", "Notice of Publication", "2016-06-20T04:00:00Z", 2016, 6, "2016-06-20T04:00:00Z", "2016-07-21T03:59:59Z", "2016-06-20T12:09:47Z", "2016-14459", 0, 0, "090000648204fcd6"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2016-P-1026-0003"], "units": {}, "query_ms": 15.285420988220721, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}